Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Donate to our blog

Your support will help Science & Enterprise continue to provide science news for business people and business news for scientists.

Affiliations

Science Blogs
ACI Profile for Alan Kotok
Featured in Alltop

Crispr-Based Diagnostics System Designed

A bioengineering team from Harvard University and Massachusetts Institute of Technology designed simple, inexpensive diagnostics tools to detect infectious diseases, based on Crispr, an emerging genome-editing technology. . . . → Read More: Crispr-Based Diagnostics System Designed

Cancer Gene Therapy Company Raises $85M in IPO

A developer of cancer immunotherapies that transfer gene treatments into patients with brain tumors is raising $85 million in its initial public stock offering. . . . → Read More: Cancer Gene Therapy Company Raises $85M in IPO

Corn, Shellfish Ingredients Enable DNA Vaccine Pills

Biomaterials researchers discovered substances from corn and shellfish can package genetic material to pass through the digestive system, making possible vaccines as pills rather than injections. . . . → Read More: Corn, Shellfish Ingredients Enable DNA Vaccine Pills

Engineered Bacteria Designed to Detect Gut Inflammation

A bioengineering team at Rice University developed a genetically modified form of bacteria that in lab mice detects inflammatory diseases in the gut. . . . → Read More: Engineered Bacteria Designed to Detect Gut Inflammation

Antibody Shows Promise Against Marburg Virus Infections

Tests with lab animals show an experimental synthetic antibody protects against deadly Marburg and Ravn viruses as long as 5 days following infections. . . . → Read More: Antibody Shows Promise Against Marburg Virus Infections

Enhanced Gene Therapy Boosts Anti-Tumor Response

Gene therapies delivered with electronic pulses were shown in lab mice to increase production of natural immune-system proteins and reduce melanoma, or advanced skin cancer, tumors. . . . → Read More: Enhanced Gene Therapy Boosts Anti-Tumor Response

Zika DNA Vaccine Begins Clinical Trial

A new clinical trial is underway testing a Zika vaccine that uses genetically-engineered DNA to generate an immune response against the disease. . . . → Read More: Zika DNA Vaccine Begins Clinical Trial

Start-Up Licensing Flexible Genome-Editing Technology

A start-up biotechnology company is licensing techniques from two universities that make genome editing more flexible and better control gene expression. . . . → Read More: Start-Up Licensing Flexible Genome-Editing Technology

CARB-X Commits $48M for Antibiotic Resistance R&D

A public-private partnership is spending $48 million in grants to biotechnology companies for research on treatments and diagnostics to counter antibiotic resistance, with half of that amount distributed immediately. . . . → Read More: CARB-X Commits $48M for Antibiotic Resistance R&D

FDA Approves Multiple Sclerosis Therapy

The Food and Drug Administration approved a synthetic targeted antibody to treat multiple sclerosis in people with relapsing or steadily worsening forms of the disease. . . . → Read More: FDA Approves Multiple Sclerosis Therapy